Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Cell Host & Microbe|January 16, 2015
A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeysAlexander D Douglas, G Christian Baldeviano, Carmen M Lucas, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications|September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2014
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trialSusanne H Hodgson, Prateek Choudhary, Sean C Elias, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Cell Host & Microbe|January 16, 2015
A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeysAlexander D Douglas, G Christian Baldeviano, Carmen M Lucas, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications|September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
Pageof 17